Assembly Biosciences, Inc. (NASDAQ:ASMB – Get Free Report) was the target of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 42,600 shares, a decrease of 29.2% from the March 15th total of 60,200 shares. Approximately 1.2% of the company’s shares are sold short. […]
StockNews.com upgraded shares of Assembly Biosciences (NASDAQ:ASMB – Free Report) from a sell rating to a hold rating in a research note published on Friday. Separately, HC Wainwright reaffirmed a neutral rating on shares of Assembly Biosciences in a research report on Monday, April 1st. Check Out Our Latest Stock Report on Assembly Biosciences Assembly […]
HC Wainwright reissued their neutral rating on shares of Assembly Biosciences (NASDAQ:ASMB – Free Report) in a research note issued to investors on Monday, Benzinga reports. HC Wainwright also issued estimates for Assembly Biosciences’ Q1 2024 earnings at ($2.74) EPS, Q2 2024 earnings at ($2.96) EPS, Q3 2024 earnings at ($3.29) EPS, Q4 2024 earnings […]
Assembly Biosciences, Inc. (NASDAQ:ASMB – Get Free Report) saw a significant drop in short interest in January. As of January 31st, there was short interest totalling 353,300 shares, a drop of 22.1% from the January 15th total of 453,600 shares. Based on an average daily trading volume, of 526,300 shares, the days-to-cover ratio is presently […]
Assembly Biosciences, Inc. (NASDAQ:ASMB – Get Free Report) saw a significant increase in short interest in January. As of January 15th, there was short interest totalling 453,600 shares, an increase of 125.7% from the December 31st total of 201,000 shares. Based on an average trading volume of 627,400 shares, the short-interest ratio is presently 0.7 […]